Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
A mega survey involving testing of 42,000 samples of Indian drugs for quality will be completed in the next six to eight months, according to GN Singh, Drugs Controller General of India (DCGI).
Speaking to newspersons on the sidelines of a conference on quality of drugs organised by the US Pharmacopoeia (USP) on Tuesday, Singh said DCGI had already commenced the testing.
“After about six months, we will actually know and tell the world that our drugs are of quality. This will also help negate misnomers as various numbers are being circulated about percentage of spurious/low quality Indian drugs,” he said.
The apex body for drug control is also ramping up its capacity. “We will be recruiting about 200 drug inspectors and assistant inspectors in next two months to strengthen our testing capabilities,” he said. At present its enforcement wing has 350 employees.
A pilot on mobile drug testing labs being run in Gujarat will also be scaled up. This year, DCGI wants to launch at least 20 more labs which will be deployed in states like Jammu & Kashmir, Bihar and UP, the official said.
FDI Visits
There will be more focus on ensuring strict adherence to Good Laboratory Practices (GLP) by the companies, he added.
When asked on measures to deal with increasing number of warning letters and other issues being faced by the Indian drug makers with the US Food and Drug Administration (USFDA), Singh said primarily it was an issue between the buyers and sellers.
“When somebody buys, they want their own rules of the game. But in a meeting with FDI team recently, we have requested it to inform us so that we can also send our inspectors along with its teams,” he said. The USFDA has positively responded.
“Already 35 to 40 per cent of all generic medicines in the US market are from India with an almost similar lead in the Europe.
“This is set to grow with the current focus on ‘Make in India’” he said.
The DCGI is also working on introducing various mechanisms for ease of operations in pharma exports.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
Here is a checklist that equips you to discern the market nuances
Sensex, Nifty 50 have witnessed sharp decline
The fund has consistently outperformed S&P BSE 100 TRI over one, three and five years
Returns are superior to immediate annuity plans, but SCSS can secure better rates for new investors sooner if ...
With the public looking beyond mainstream media for reports from the ground, independent digital platforms are ...
The country hasn’t had a quiet moment since the military seized power on February 1
The Tatmadaw sees itself as an embodiment of the nationalist soul of Myanmar. But their brand of nationalism ...
While Supreme Court has cleared the way for women seeking longer tenures and senior roles in the Indian Army, ...
Its name is the starting point of a brand’s journey and can make a big difference in the success sweepstakes
Sober spirits are the in thing
A peek into where ad spends went last year and where they are headed tomorrow
Can Swiggy Instamart disrupt the ecommerce groceries space, currently ruled by the Amazons and Big Baskets? ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor